J.M. Scherrmann

899 total citations
23 papers, 688 citations indexed

About

J.M. Scherrmann is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, J.M. Scherrmann has authored 23 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in J.M. Scherrmann's work include Drug Transport and Resistance Mechanisms (9 papers), Poisoning and overdose treatments (3 papers) and Chemical Synthesis and Analysis (2 papers). J.M. Scherrmann is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Poisoning and overdose treatments (3 papers) and Chemical Synthesis and Analysis (2 papers). J.M. Scherrmann collaborates with scholars based in France and Germany. J.M. Scherrmann's co-authors include Maria Smirnova, P. Sandouk, M. Urtizberea, Jamal Temsamani, Christophe Rousselle, Jeanne-Marie Lefauconnier, Bernard Calas, Alain Chavanieu, A Gilton and P Clair and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.

In The Last Decade

J.M. Scherrmann

23 papers receiving 661 citations

Peers

J.M. Scherrmann
Jean‐Michel Scherrmann France
Emil Samara United States
Marı́a P. Carrasco Spain
Mie Kristensen Denmark
A. Schmal Germany
William J. Daily United States
E Pastoriza-Muñoz United States
James C. Cradock United States
Xiaoyun Li China
Jianfang Li China
Jean‐Michel Scherrmann France
J.M. Scherrmann
Citations per year, relative to J.M. Scherrmann J.M. Scherrmann (= 1×) peers Jean‐Michel Scherrmann

Countries citing papers authored by J.M. Scherrmann

Since Specialization
Citations

This map shows the geographic impact of J.M. Scherrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Scherrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Scherrmann more than expected).

Fields of papers citing papers by J.M. Scherrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Scherrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Scherrmann. The network helps show where J.M. Scherrmann may publish in the future.

Co-authorship network of co-authors of J.M. Scherrmann

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Scherrmann. A scholar is included among the top collaborators of J.M. Scherrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Scherrmann. J.M. Scherrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapy, Hélène, Maria Smirnova, Patrice André, et al.. (2014). Carrier-Mediated Cocaine Transport at the Blood-Brain Barrier as a Putative Mechanism in Addiction Liability. The International Journal of Neuropsychopharmacology. 18(1). pyu001–pyu001. 39 indexed citations
2.
Manceau, Sandra, Xavier Declèves, J.M. Scherrmann, et al.. (2012). ABC drug transporter and nuclear receptor expression in human cytotrophoblasts: Influence of spontaneous syncytialization and induction by glucocorticoids. Placenta. 33(11). 927–932. 25 indexed citations
3.
Manceau, Sandra, Xavier Declèves, Frédéric Batteux, et al.. (2010). Lack of P-glycoprotein induction by rifampicin and phenobarbital in human lymphocytes. International Journal of Pharmaceutics. 395(1-2). 98–103. 12 indexed citations
4.
Tröger, Uwe, Hartmut Lins, J.M. Scherrmann, Claus-Werner Wallesch, & Stefanie M. Bode‐Böger. (2005). Tetraparesis associated with colchicine is probably due to inhibition by verapamil of the P-glycoprotein efflux pump in the blood-brain barrier. BMJ. 331(7517). 613.1–613.1. 16 indexed citations
5.
Ansoborlo, É., et al.. (2003). Study of uranium transfer across the blood-brain barrier. Radiation Protection Dosimetry. 105(1-4). 243–245. 47 indexed citations
6.
Scherrmann, J.M.. (2002). Drug delivery to brain via the blood–brain barrier. Vascular Pharmacology. 38(6). 349–354. 129 indexed citations
7.
Rousselle, Christophe, Maria Smirnova, P Clair, et al.. (2001). Enhanced Delivery of Doxorubicin into the Brain via a Peptide-Vector-Mediated Strategy: Saturation Kinetics and Specificity. Journal of Pharmacology and Experimental Therapeutics. 296(1). 124–131. 131 indexed citations
8.
Risède, Patricia, et al.. (1997). Role of P-170 glycoprotein in colchicine brain uptake. Journal of Neuroscience Research. 49(1). 80–88. 20 indexed citations
9.
Scherrmann, J.M., et al.. (1997). Regioselective Hydrolysis of Cocaine and A Convenient Acylation Procedure by Benzoylecgonine. Synthetic Communications. 27(19). 3485–3490. 3 indexed citations
10.
Risède, Patricia, et al.. (1997). Role of P-170 glycoprotein in colchicine brain uptake.. PubMed. 49(1). 80–8. 24 indexed citations
11.
Choumet, Valérie, F. Audebert, Gilles Rivière, et al.. (1996). New Approaches in Antivenom Therapy. Advances in experimental medicine and biology. 391. 515–520. 3 indexed citations
12.
Sandré, Catherine, et al.. (1995). Immunoreactivity of Endogenous Digitalis-Like Substances in Cord Blood Sera Studied with Antidigitoxin Monoclonal Antibodies. Therapeutic Drug Monitoring. 17(1). 19–24. 2 indexed citations
13.
Faessel, Hélène M., J.M. Scherrmann, Pascal Houzé, & Frédéric J. Baud. (1995). 4-Methylpyrazole monitoring during haemodialysis of ethylene glycol intoxicated patients. European Journal of Clinical Pharmacology. 49(3). 211–3. 21 indexed citations
14.
Sandouk, P., et al.. (1994). Single‐dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers. Biopharmaceutics & Drug Disposition. 15(1). 87–92. 15 indexed citations
15.
Dhonneur, G., A Gilton, P. Sandouk, J.M. Scherrmann, & P. Duvaldestin. (1994). Plasma and Cerebrospinal Fluid Concentrations of Morphine and Morphine Glucuronides after Oral Morphine. Anesthesiology. 81(1). 87–93. 78 indexed citations
16.
Sabouraud, A., et al.. (1993). Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.. Drug Metabolism and Disposition. 21(6). 997–1002. 6 indexed citations
17.
Urtizberea, M., A. Sabouraud, Frédéric J. Baud, et al.. (1992). Concepts for Toxicokinetic-Toxicodynamic Modelling in Clinical Toxicology: Application to Acute Cardiac Glycoside Intoxications. Archives of toxicology. Supplement. 15. 253–256. 3 indexed citations
18.
Sabouraud, A., et al.. (1992). Colchicine-specific Fab fragments alter colchicine disposition in rabbits.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1214–1219. 36 indexed citations
19.
Urtizberea, M., et al.. (1990). Reversal of advanced colchicine toxicity in mice with goat colchicine-specific antibodies. Toxicology and Applied Pharmacology. 104(3). 504–510. 23 indexed citations
20.
Sabouraud, A., et al.. (1990). Specific Anti-digoxin Fab Fragments: an Available Antidote for Proscillaridin and Scilliroside Poisoning?. Human & Experimental Toxicology. 9(3). 191–193. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Michel Scherrmann Breakdown of academic impact, for papers by Emil Samara Breakdown of academic impact, for papers by Marı́a P. Carrasco Breakdown of academic impact, for papers by Mie Kristensen Breakdown of academic impact, for papers by A. Schmal Breakdown of academic impact, for papers by William J. Daily Breakdown of academic impact, for papers by E Pastoriza-Muñoz Breakdown of academic impact, for papers by James C. Cradock Breakdown of academic impact, for papers by Xiaoyun Li Breakdown of academic impact, for papers by Jianfang Li
Rankless by CCL
2026